Risk factors and prodromal markers and the development of Parkinson's disease

Journal of Neurology

Volumn 261, Issue 1, 2014, Pages 180-187

  Lerche, Stefanie ^a,b   Seppi, Klaus ^c   Behnke, Stefanie ^d   Liepelt Scarfone, Inga ^a,b   Godau, Jana ^a,b   Mahlknecht, Philipp ^c   Gaenslen, Alexandra ^a,b   Brockmann, Kathrin ^a,b   Srulijes, Karin ^a,b   Huber, Heiko ^a,b   Wurster, Isabel ^a,b   Stockner, Heike ^c   Kiechl, Stefan ^c   Willeit, Johann ^c   Gasperi, Arno ^e   Fassbender, Klaus ^d   Poewe, Werner ^c   Berg, Daniela ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d SAARLAND UNIVERSITY   (Germany)

^e BRUNECK HOSPITAL   (Italy)

Author keywords

Parkinson's disease; Prodromal marker; Risk factor

Indexed keywords

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOOD DISORDERS; OLFACTION DISORDERS; PARKINSON DISEASE; PRODROMAL SYMPTOMS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84895076286     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7171-0     Document Type: Article

References (40)

1. Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26(5):775-783
2. Stern MB, Lang A, Poewe W (2012) Toward a redefinition of Parkinson's disease. Mov Disord 27(1):54-60
3. de Rijk MC, Launer LJ, Berger K et al (2000) Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 (11 Suppl 5):S21-S23
4. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ (2005) Gender and the Parkinson's disease phenotype. J Neurol 252(10):1201-1205
5. Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB (2007) Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Mov Disord 22(15):2249-2255
6. Berg D, Seppi K, Behnke S et al (2011) Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1,847 older persons. Arch Neurol 68(7):932-937
7. Ross GW, Petrovitch H, Abbott RD et al (2008) Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 63(2):167-173
8. Tolosa E, Compta Y, Gaig C (2007) The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 13 Suppl:S2-S7
9. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR (2003) Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18(4):414-418
10. Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5(7):572-577
11. de Lau LML, Koudstaal PJ, Hofman A, Breteler MMB (2006) Subjective complaints, precede Parkinson disease - The Rotterdam study. Arch Neurol 63(3):362-365
12. Louis ED, Bennett DA (2007) Mild Parkinsonian signs: an overview of an emerging concept. Mov Disord 22(12):1681-1688
13. Berg D, Seppi K, Liepelt I et al (2010) Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly. Mov Disord 25(10):1464-1469
14. Postuma RB, Gagnon JF (2011) Symmetry of Parkinson's disease and REM sleep: one piece of the puzzle. Ann Neurol 69(5):905
15. Berg D, Marek K, Ross GW, Poewe W (2012) Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov Disord 27(5):656-665
16. Marder K, Tang MX, Mejia H et al (1996) Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 47(1):155-160
17. Berg D, Behnke S, Walter U (2006) Application of transcranial sonography in extrapyramidal disorders: updated recommendations. Ultraschall Med 27(1):12-19
18. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G, Berg D (2007) Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 33(1):15-25
19. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994) Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 9(1):76-83
20. Louis ED, Luchsinger JA, Tang MX, Mayeux R (2003) Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology 61(1):24-28
21. Louis ED, Tang MX, Mayeux R (2004) Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol 61(8):1273-1276
22. Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110(10):976-981
23. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW (1997) Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 12:871-876
24. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR (2003) Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18:414-418
25. Ford B (2010) Pain in Parkinson's disease. Mov Disord 25 (Suppl 1):S98-S103
26. Ehrt U, Larsen JP, Aarsland D (2009) Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry 17:269-275
27. Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D (2011) The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease. Mov Disord 26(4):653-658
28. Kurz M, Alves G, Aarsland D, Larsen JP (2003) Familial Parkinson's disease: a community-based study. Eur J Neurol 10(2):159-163
29. Ruprecht-Dorfler P, Berg D, Tucha O et al (2003) Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 18(2):416-422
30. Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY (2012) How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 135 (Pt 6):1860-1870
31. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56(2):173-181
32. Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson's disease - Effects of antiparkinsonian treatment and guidelines for management. Drug Aging 10(4):249-258
33. Abbott RD, Petrovitch H, White LR et al (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57(3):456-462
34. Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 53:463-468
35. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME (2008) Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 8:5
36. Copeland JR, Beekman AT, Braam AW et al (2004) Depression among older people in Europe: the EURODEP studies. World Psychiatry 3(1):45-49
37. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR (2012) Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord 18 (Suppl 1):S199-S202
38. Siderowf A, Jennings D, Eberly S et al (2012) Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 27(3):406-412
39. Liepelt I, Behnke S, Schweitzer K et al (2011) Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol Aging 32(9):1599-1606
40. Berg D, Godau J, Seppi K et al (2013) The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 20(1):102-108